AJP - GI Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Gastrointest Liver Physiol 282: G1-G5, 2002; doi:10.1152/ajpgi.00384.2001
0193-1857/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (49)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Diehl, A. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Diehl, A. M.
Vol. 282, Issue 1, G1-G5, January 2002

THEME
Nonalcoholic Steatosis and Steatohepatitis
IV. Nonalcoholic fatty liver disease abnormalities in macrophage function and cytokines

Anna Mae Diehl

Department of Medicine, The Johns Hopkins University, Baltimore, Maryland 21205

Macrophage products, such as cytokines, prostanoids, nitric oxide, and reactive oxygen intermediates, influence the function and viability of macrophages and neighboring cells. Given that the liver has one of the largest resident macrophage populations in the body, it is not surprising that hepatic macrophages [i.e., Kupffer cells (KC)] are involved in the pathogenesis of many kinds of liver disease. This review summarizes the abnormalities that have been demonstrated in bone marrow, peritoneal and hepatic macrophage of leptin-resistant (fa/fa) rats and leptin-deficient (ob/ob) mice, two animal models for nonalcoholic fatty liver disease (NAFLD). Evidence supports the concept that altered KC function influences the viability of other cells, such as lymphocytes and hepatocytes, in fatty livers, thereby contributing to the pathogenesis of NAFLD in animals with reduced leptin activity. Further work is needed to determine whether KC dysfunction is a component of more generalized mechanisms that lead to NAFLD.

steatohepatitis; innate immunity; leptin


This article has been cited by other articles:


Home page
Pharmacol. Rev.Home page
N. Anderson and J. Borlak
Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis
Pharmacol. Rev., September 1, 2008; 60(3): 311 - 357.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
C. Pagano, G. Soardo, W. Esposito, F. Fallo, L. Basan, D. Donnini, G. Federspil, L. A Sechi, and R. Vettor
Plasma adiponectin is decreased in nonalcoholic fatty liver disease
Eur. J. Endocrinol., January 1, 2005; 152(1): 113 - 118.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. Kerner, O. Avizohar, R. Sella, P. Bartha, O. Zinder, W. Markiewicz, Y. Levy, G. J. Brook, and D. Aronson
Association Between Elevated Liver Enzymes and C-Reactive Protein: Possible Hepatic Contribution to Systemic Inflammation in the Metabolic Syndrome
Arterioscler. Thromb. Vasc. Biol., January 1, 2005; 25(1): 193 - 197.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
M Pizarro, N Balasubramaniyan, N Solis, A Solar, I Duarte, J F Miquel, F J Suchy, M Trauner, L Accatino, M Ananthanarayanan, et al.
Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function
Gut, December 1, 2004; 53(12): 1837 - 1843.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Sahai, P. Malladi, H. Melin-Aldana, R. M. Green, and P. F. Whitington
Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G264 - G273.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. M. Grundy
Inflammation, Hypertension, and the Metabolic Syndrome
JAMA, December 10, 2003; 290(22): 3000 - 3002.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online